a day ago
AVBP
AnalystsYigal NochomovitzYigal Nochomovitz's Stock Forecasts
AnalystsYigal Nochomovitz
Sectors:
Analyst Ranking
Top 5%
#205 out of 4671 analysts
Average Return
+11.33%
Win Rate
45%95 out of 212
Risk vs Reward
Poor
Good
Yigal Nochomovitz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Applied Therapeutics IncAPLT | +640.00% | $0.80 | $5.92 | 2023-04-04 - 2024-04-04 | Strong Buy |
Harpoon Therapeutics IncHARP | +381.72% | $4.76 | $22.93 | 2023-09-17 - 2024-02-26 | Strong Buy |
Reata Pharmaceuticals IncRETA | +334.02% | $38.27 | $166.10 | 2022-11-08 - 2023-08-01 | Strong Buy |
Harpoon Therapeutics IncHARP | +327.80% | $5.36 | $22.93 | 2023-10-23 - 2024-02-26 | Strong Buy |
Summit Therapeutics IncSMMT | +327.50% | $5.31 | $22.70 | 2024-05-06 - 2024-09-11 | Strong Buy |
Yigal Nochomovitz Analyst Color
Get additional color on Yigal Nochomovitz's coverage of popular stocks
3 days ago
SMMT
16 days ago
APLT
a month ago
SNDX
a month ago
BGNE
a month ago
ARDX
3 months ago
MRUS
3 months ago
RCUS
3 months ago
SMMT
4 months ago
ARDX
6 months ago
IDYA
6 months ago
MGNX
7 months ago
KRYS
7 months ago
APLT
7 months ago
ARCT
8 months ago
ARDX
9 months ago
MGNX
a year ago
BMEA
a year ago
RARE
a year ago
LXRX
a year ago
APLS
a year ago
MRUS
Yigal Nochomovitz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arrivent Biopharma IncAVBP | 2 | Strong Buy | $36.00 | +41.96% | Maintains | a day ago |
Summit Therapeutics IncSMMT | 3 | Strong Buy | $19.00 | -16.30% | Maintains | 3 days ago |
Ideaya Biosciences IncIDYA | 3 | Strong Buy | $58.00 | +60.22% | Maintains | 16 days ago |
Biomea Fusion IncBMEA | 8 | Strong Buy | $22.00 | +191.01% | Maintains | 16 days ago |
Applied Therapeutics IncAPLT | 5 | Strong Buy | $8.00 | +53.55% | Maintains | 16 days ago |
Syndax Pharmaceuticals IncSNDX | 6 | Strong Buy | $34.00 | +85.59% | Maintains | a month ago |
Macrogenics IncMGNX | 10 | Strong Buy | $14.00 | +286.74% | Maintains | a month ago |
Shattuck Labs IncSTTK | 3 | Strong Buy | $8.00 | +114.48% | Maintains | a month ago |
Beigene LtdBGNE | 4 | Strong Buy | $288.00 | +36.40% | Maintains | a month ago |
Krystal Biotech IncKRYS | 2 | Hold | $204.00 | +2.62% | Downgrades | a month ago |
Ardelyx IncARDX | 9 | Strong Buy | $12.00 | +101.34% | Maintains | a month ago |
Merus NvMRUS | 13 | Strong Buy | $93.00 | +84.96% | Maintains | 3 months ago |
Ovid Therapeutics IncOVID | 6 | Hold | $1.20 | +7.14% | Maintains | 3 months ago |
Arcus Biosciences IncRCUS | 6 | Strong Buy | $38.00 | +123.92% | Maintains | 3 months ago |
Calliditas Therapeutics AbCALT | 2 | Hold | $39.00 | -2.01% | Downgrades | 3 months ago |
Crispr Therapeutics AgCRSP | 17 | Strong Buy | $84.00 | +84.86% | Maintains | 4 months ago |
Apellis Pharmaceuticals IncAPLS | 11 | Strong Buy | $60.00 | +56.41% | Maintains | 4 months ago |
Oric Pharmaceuticals IncORIC | 5 | Strong Buy | $14.00 | +41.41% | Maintains | 4 months ago |
Zymeworks IncZYME | 10 | Strong Buy | $16.00 | +32.23% | Maintains | 4 months ago |
Proqr Therapeutics NvPRQR | 3 | Hold | $2.00 | +8.11% | Maintains | 5 months ago |
Lenz Therapeutics IncLENZ | 1 | Strong Buy | $34.00 | +60.98% | Initiates Coverage On | 5 months ago |
Rigel Pharmaceuticals IncRIGL | 9 | Strong Buy | $40.00 | +208.40% | Maintains | 6 months ago |
Zai Lab LtdZLAB | 7 | Strong Buy | $66.00 | +205.98% | Maintains | 6 months ago |
Harpoon Therapeutics IncHARP | 9 | Hold | $23.00 | -0.04% | Downgrades | 7 months ago |
Arvinas IncARVN | 7 | Hold | $55.00 | +120.97% | Downgrades | 7 months ago |
Arcturus Therapeutics Holdings IncARCT | 5 | Strong Buy | $48.00 | +128.79% | Maintains | 7 months ago |
Olema Pharmaceuticals IncOLMA | 1 | Strong Buy | $20.00 | +62.07% | Initiates Coverage On | 7 months ago |
Mirati Therapeutics IncMRTX | 11 | Hold | $59.00 | +0.51% | Downgrades | 9 months ago |
Aldeyra Therapeutics IncALDX | 8 | Strong Buy | $8.00 | +29.24% | Maintains | a year ago |
Rain Oncology IncRAIN | 4 | Hold | $1.00 | -17.36% | Maintains | a year ago |
Eiger Biopharmaceuticals IncEIGRQ | 3 | Strong Buy | $90.00 | N/A | Maintains | a year ago |
Gracell Biotechnologies IncGRCL | 2 | Strong Buy | $11.00 | N/A | Maintains | a year ago |
Galera Therapeutics IncGRTX | 2 | Hold | $0.25 | N/A | Maintains | a year ago |
Atara Biotherapeutics IncATRA | 11 | Strong Sell | $35.00 | N/A | Maintains | a year ago |
Reata Pharmaceuticals IncRETA | 8 | Hold | $172.50 | N/A | Downgrades | a year ago |
Ultragenyx Pharmaceutical IncRARE | 10 | Strong Buy | $133.00 | N/A | Maintains | a year ago |
Lexicon Pharmaceuticals IncLXRX | 5 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Unity Biotechnology IncUBX | 6 | Strong Buy | $6.00 | N/A | Maintains | a year ago |
Cellectis SaCLLS | 2 | Strong Buy | $16.00 | N/A | Maintains | a year ago |
Fate Therapeutics IncFATE | 3 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Prokidney CorpPROK | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 2 years ago |
Opthea LtdOPT | 2 | Strong Buy | $44.00 | N/A | Maintains | 2 years ago |
Innate Pharma SaIPHA | 1 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Caribou Biosciences IncCRBU | 4 | Strong Buy | $38.00 | N/A | Maintains | 2 years ago |
Aerie Pharmaceuticals IncAERI | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $32.00 | N/A | Downgrades | 3 years ago |
Acceleron Pharma IncXLRN | 1 | Strong Buy | $171.00 | N/A | Maintains | 4 years ago |
Puma Biotechnology IncPBYI | 5 | Strong Buy | $70.00 | N/A | Maintains | 6 years ago |
Loxo Oncology IncLOXO | 6 | Strong Buy | $213.00 | N/A | Maintains | 6 years ago |
Keryx Biopharmaceuticals IncKERX | 2 | Hold | $4.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.